𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Pegylated liposomal doxorubicin in the treatment of cutaneousT-cell lymphoma

✍ Scribed by H.Miles Prince; J.F. Seymour; Gail Ryan; Chris McCormack

Book ID
117844772
Publisher
Elsevier Science
Year
2001
Tongue
English
Weight
59 KB
Volume
44
Category
Article
ISSN
1097-6787

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Multicenter study of pegylated liposomal
Multicenter study of pegylated liposomal doxorubicin in patients with cutaneous T-cell lymphoma
✍ Uwe Wollina; Reinhard Dummer; Norbert H. Brockmeyer; Helga Konrad; J.-O. Busch; πŸ“‚ Article πŸ“… 2003 πŸ› John Wiley and Sons 🌐 English βš– 96 KB

## Abstract ## BACKGROUND In single center studies and case reports, it was shown that pegylated liposomal doxorubicin (PEG‐DOXO) was effective as second‐line therapy for patients with cutaneous T‐cell lymphoma (CTCL). The objective of this study was to evaluate the efficacy and toxicity of single